Health ❯ Healthcare ❯ Medical Research ❯ Oncology

Pancreatic Cancer

Experimental Drug Elraglusib Extends Survival in Phase 2 Pancreatic Cancer Trial

The findings set up a phase 3 test before doctors can use the drug widely.

Spanish Team Eradicates Pancreatic Tumors in Mice With Triple-Drug Regimen, PNAS Study Finds

Splice-Switching ASO Collapses Oncogenic Circuit in Pancreatic Cancer Models